Litigation Details for ASSERTIO THERAPEUTICS, INC. v. ACTAVIS ELIZABETH LLC (D.N.J. 2015)
✉ Email this page to a colleague
ASSERTIO THERAPEUTICS, INC. v. ACTAVIS ELIZABETH LLC (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-09-11 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-04-11 |
| Cause | 35:145 Patent Infringement | Assigned To | Claire Claudia Cecchi |
| Jury Demand | None | Referred To | Mark Falk |
| Patents | 8,536,130 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASSERTIO THERAPEUTICS, INC. v. ACTAVIS ELIZABETH LLC
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for ASSERTIO THERAPEUTICS, INC. v. ACTAVIS ELIZABETH LLC (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-09-11 | 1 | prior to the expiration of U.S. Patent No. 8,536,130 (“the ’130 Patent”). THE PARTIES: PLAINTIFFS 2.…ACTION 1. This is an action for patent infringement under the patent laws of the United States, Title…act of patent infringement, and intends a future course of conduct that includes acts of patent infringement… U.S.C. §§ 1391 and 1400(b). THE PATENT-IN-SUIT 23. The ’ 130 Patent, entitled “USE OF 1 PHENYL-3-DIMETHYLAMINO…the ’ 130 Patent is attached hereto as Exhibit 1. 24. Claims l, 2 and 4 of the ’ 130 Patent claim, inter | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
